PA48009,a lanthionine-containing peptide antibiotic was isolated from the culture broth of Streptoverticillium griseoverticillatum PA-48009, and identified as duramycin. Determination of the structure using both Edmandegradations and 2D NMR spectroscopy showed the need to revise the structure of duramycin given in literature. Duramycin (PA48009) was different from lanthiopeptin (Ro 09-0198, cinnamycin) only by a Lys/Arg exchange at position 2.
(Received for publication March 24, 1990) PA48009,a lanthionine-containing peptide antibiotic was isolated from the culture broth of Streptoverticillium griseoverticillatum PA-48009, and identified as duramycin. Determination of the structure using both Edmandegradations and 2D NMR spectroscopy showed the need to revise the structure of duramycin given in literature. Duramycin (PA48009) was different from lanthiopeptin (Ro 09-0198, cinnamycin) only by a Lys/Arg exchange at position 2.
During screening of new biologically active compounds, PA48009 (1), a lanthionine-containing peptide antibiotic, was isolated from the fermentation broth of Streptoverticillium griseoverticillatum PA-48009. It exhibited weak antimicrobial activity against Gram-positive organisms. Several lanthionine-containing peptide antibiotics have been reported already1~n). Recent development of NMRmethodology and instrumentation12 '13) make it possible to analyze NMRspectra and to determine the conformation of small proteins and oligopeptides. The structure of Ro 09-0198 was reported by Kessler et al.lt8\ but the reported structure showed some discrepancies with that of lanthiopeptin (3) ( = Ro 09-0198) reported by Wakamiya et al.3) . Weconsidered that this problem had arisen from the difficulty in discriminating the amino acid residue as Ala or Phe in the sequence analysis using NMR. Therefore, we employed both NMRarid Edmandegradation methods to analyze the structure of 1. The discrimination of the Phe residue from the Ala residue was possible with Edmandegradation, and the sulfide bridges in the lanthionine (Lan) and methyllanthionine (MeLan) moiety and the NHbridge in the lysinoalanine (LysAla) moiety were easily determined by analyzing the NOESYspectra. As PA48009 (1) was identified as duramycin1'2) by physical measurements, wereport here the revised structure of duramycin (1) as shownin Fig. 1 . NOV. 1990 PA48009 (1) was purified from fermentation broth filtrate by Diaion HP-20, ion exchange resin and silica gel chromatographies. Acid hydrolysis of 1 with 6 n HC1 gave several ninhydrin-positive compounds. Ten commonamino acids (L-Asp, l-G1u, L-Pro, L-Gly (2), L-Val, L-Phe (3), L-Lys) and five unusual amino acids {/Miydroxyaspartic acid (HOAsp), raeso-Lan, /?-Melan (2) and LysAla} were isolated by preparative paper and ion exchange chromatographies. The structures of these four unusual aminoacids were determined by MSand NMRstudies and that of Lan was confirmed by X-ray analysis (T. Sato: Shionogi Res. Lab., unpublished data). The absolute configurations of their usual amino acids were determined to be all L-forms by HPLCanalysis using chiral columns. The molecular formula of 1 was established as CggH^s^aC^sSg by MS and the elemental analysis. Compound 1 and duramycin1'2* resembled one another. They had similar amino acids except for the replacement of the glutamine of 1 with a glutamic acid and Ala6 vs. Abu6. Peptide 1 differed from duramycin because the optical rotation of duramycin (HC1 salts)1} was reported to be -6.4°(c 3.9, H2O), while that of 1 (HC1 salt) was -91.1°(c 0.515, H2O). Also, the third and the fifth cycle amino acids of duramycin were reported to be glutamic acid (Glu) and LysAla by Gross and Brown2), but those of 1 were determined to be glutamine (Gin) and MeLan by Edman degradation. However, 1 was definitely identified with an authentic sample of duramycin2) by comparison of physical measurements as shown in Table 1 .
To determine the amino acid sequence of 1, Edmandegradations were applied to the intact molecule and several peptides obtained by chemical or enzymic modification are shown in Fig. 2 .
As a result of Edmandegradation, the linear sequence of 1, except for four bridged amino acids (Lan, two MeLan and LysAla) was established as shown in Fig. 2(e) . The positions of the four bridged amino acids were finally determined to be Ala^S-Abu18, Ala5-S-Abu1 1 for MeLan, Ala4-S-Ala14 for Lan and Ala6-Lys19 for LysAla by analysis of the 2D NMRspectra of 1.
NMRAnalysis
NMRanalysis was conducted with the sequential information of Edman degradation as shown in Fig.  2 (e). Fig. 3 shows a double quantum filtered phase sensitive (DQF)-COSY spectrum of 1 at 23°C and pH 3 .0. Under these conditions, we found 13 cross peaks in the fingerprint region. Since 18 cross peaks Both spectra were identical.
Their aminoacids compositions were the same and Edmandegradations were identical until the 5th cycle amino acid.a
X^Lys^Gln^-X5-?6. {19 -l(Pro)} were expected in this region, we searched under other pH and temperature conditions. Fig. 4 shows the single relayed coherence transferred COSY(RELAY)spectrum of 1 at 60°C and pH 3.0. Whenthe temperature was raised to 60°C, three additional cross peaks appeared. The two other amide protons could not be detected. The through bond connectivities from amide NHto yCHwere confirmed for all the amide proton signals. As a result, we also found three (19-16) sets of aCH-/?CHcross peaks in the aliphatic region (arrows in the figure), which came from amino acid residues with no (Pro) or an undetectable amide proton of the main chain. At this stage, we could confirm the 19 amino acid residues of1 using 2D NMRspectra.
Residue Type Assignments: Compound1 includes amino acid residues of ten kinds. Amongthem, Abu and Val could be determined easily from the other residues by the coupling pattern with methyl groups, and Asn and Gin by the coupling pattern and NOE(s) with the amide protons of the side chain. The distinction between Lys and Pro was very easy because the former had an amide proton while the latter did not. Discrimination of HOAspfrom Gly was a little troublesome because of the degeneration of the amide NH, aCH and /?CH proton resonance shift. However, the spin system of HOAspdiffers from that of Gly. Using the multiplet pattern of the cross peak in the DQF-COSY spectrum, they were discriminable. However, the distinction between Ala and Phe for a few of the residues was difficult, because of the degeneration of the aCHand the /?CH proton resonance shifts and the uncertainty ofNOE(s) between the aliphatic proton and ring proton signals of Phe. As described below, the use of data from both NMR analysis and Edmandegradations enabled us to make the distinction.
Sequential Assignments: Fig. 5 shows the fingerprint region of the NOESYspectrum at pH 3.0 and 60°C. The peptide chain was searched sequentially by / coupling and NOE(daN) between amide NH and aCH signals. Information on sequential NOEbetween the amide NHand /? proton signals (d^N) and between main chain amide protons (dNN)were also used to confirm the sequence (data not shown). As shown in Fig. 5 , we obtained five segments A~E. Segment A, which consists of 5 amino acid residues, starts from the daN cross-peak between Ala and Lys. The sequential connectivities of Lys-Gln, Gin-Ala and Ala-Ala were confirmed by the strong daN NOESYpeaks12'13). Determination of the next residue, however, was difficult because of overlapping of the other two aCHresonances. Segment B was identified in the same way. It starts from the unequivalent intraresidue aCH-NHNOEpeaks of Gly and ends at the intraresidue aCH-NHNOEpeak of Lys (Gly-Asn-Abu-Lys). Moreover, an additional residue of HOAspwas found at the Af-terminal side of the segment on analyzing the 2D spectra measured under other conditions (pH 3.0, 23°C). Thus, segment B was determined to be HOAsp-Gly-Asn-Abu-Lys. The sequence of (Ala or Phe)-Phe-Gly was found to be in segment C. On comparison with the result of Edmandegradation, the sequence of Ala-Phe-Gly was determined to be segment C. This cleared any uncertainty about the distinction of residue type being Ala or Phe. Segment D contained only two residues (Val-Ala). The daN cross peak with the next residue could not be correlated with an individual residue because of the degeneracy of three NHresonances. Segment E was found to consist of the sequence Pro-Phe-Abu. All the residues of segments A~Ecould be assigned through this process. The sequential arrangement of the five segments was exclusively determined by comparison with the Edmandegradations as following:
Ala^Lys^Gln^-Ala4-^Ĝ ly16-Asn17-Abu18-Lys19. The information obtained from NMRanalysis and from Edman degradations were complementary for the sequence determination. Some kinds of residues, which were ambiguous in the Edman degradation experiment, were easily determined by 2D NMRanalysis. On the other hand, the arrangement of segments and the determination of Phe or Ala were clarified by comparison with the results of Edmandegradation. All the NMRsignals could be assigned, except for three phenylalanine ring protons, and are listed in Table 2 . Assignments of Sulfide Bridge and NHBridge Connections: The NHand S bridge connections could not be determined directly by /-coupling analysis, because the bridged NH signal of LysAla of 1 in *H NMRwas not detected under various conditions (at 23~60°C, pH 3~7) and the long-range HETCOR experiment could not be done on account of low solubility of 1 in DMSO. These bridges were confirmed by the observation of NOEconnectivities across the nitrogen and sulfur atoms, namely the /?CH(AlaNH)-
the £CH(Alas)-£CH(Alas) and the £CH(Abus)-jftCH(Alas) connectivities. Investigation of possible conformations of Lan, MeLanand LysAla by using molecular models showed that the distances among the protons across the N or S bridges were short enough for giving clear NOESYpeaks. Fig. 6 shows the jftCH and SCHregion of the NOESYspectrum at 23°C. Each jffCH and SCHsignal showed only a pair of interresidue NOEcross peaks. Therefore, we could exclusively determine sulfide and NHbridge pairs, i.e., Ala^S-Abu18, Ala4-S-Ala14, Ala^S-Abull and Ala6-NH-Lys19. Thus, the primary structure of 1 shown in Fig. 1 was confirmed.
Comparison with Duramycin: The *H NMRspectrum of duramycin was regarded to be identical with that of 1. Duramycin also exhibited the two singlet signals at 6.66 and 7.07ppm assigned to protons of the Gin3. Slight differences found between the isolated spectra converged into the same chemical shifts in the spectrum of the 1 : 1 mixture. This was also confirmed by 2D NMRanalyses.
Conclusion
Duramycin (PA48009) differed from the recently discovered tetracyclic 1 9-residue peptide lanthiopeptin (Ro 09-0198, cinnamycin)3'7'8) only in the Lys/Arg exchange at position 2. Three sulfide bonds were formed in the same way along them and the NHbridge was identical with that of lanthiopeptin. This conforms to the fact that the 2D NMRspectra of 1 showedalmost the same spectral pattern as that of Ro 09-01987). This probably indicates that the stereochemical configurations of Lan, MeLanand LysAla in PA48009 and lanthiopeptin are identical, leading to good sequence homology among them.
Experimental
Amino Acid Analysis and Sequence Determination Samples were hydrolyzed with 6n HC1for 20hours at 110°C. Aminoacid analyses were performed with a Hitachi amino acid autoanalyzer (Model 835). Automated Edman degradation was carried out with an Applied Biosystems protein sequencer 477A equipped with a phenylthiohydantoin-amino acid analyzer (Model 120A). Mass spectra were obtained with a Hitachi M-90 spectrometer. NMRspectra were measured with a Varian XL-400 spectrometer. Almost all the 2DNMRspectra were recorded in DMSO-J6 solution of 20mg of the sample (pH 3.0) and 0.4ml at 23°C or 60°C. NMR spectra for comparison of duramycin2) and 1 were obtained with solution of 4.7~4.8mg of sample and 0.35 ml of DMSO-d6 at 30°C. DQF-COSYand absolute mode RELAYexperiments were conducted for spin system assignment. Phase sensitive 2D NOESYexperiments were also employed in the main chain directed sequential assignment and the determination of the bridge structure. NMRspectra were generally recorded with 2,048 complex points and 48 to 96 scans for each free induction decay. Usually 256 t1 increments were collected for each 2Dspectrum. Spectrum width was 4,800 or 4,900 Hz in both dimensions. NOESYspectra were recorded using 250 mseconds (at 23°C) and 350 mseconds (at 60°C) for mixing times.
A total mixing period of 31.3mseconds was used in single RELAY experiments. FID sets were fourier-transformed in both dimensions after multiplication with a Lorentz-to-Gauss weighting function for phase sensitive spectra and with a pseudo-echo weighting function for absolute modespectra. The final matrix contained 2,048 real points in the t2 dimension and 1,024 points in the tj dimension.
Fermentation and Isolation of PA48009 (1) NOV. 1990
Strain PA-48009 was cultured for 2 days at 28°C in a medium containing 0.5% of soluble starch, 0.5% of glucose, 0.5% of Polypeptone, 0.5% of beef extract, 0.5% of yeast extract, and 0.25% of NaCl. The seed was cultured for 3 days at 28°C in a medium containing 2.0% of glucose, 2.0% of potato starch, 2.0% of soybean meal, 0.5% of yeast extract, 0.25% of NaCl, 0.3% of CaCO3. For isolation, the fermentation culture was filtered, and the filtrate (153 liters) was applied to a column of Diaion HP-20 (2 liters) and eluted with 0.1 m AcOH-MeOH.The eluate was lyophilized, giving a crude material (10.62 g), which was dissolved in 25% PrOH (200ml) and chromatographed on silica gel (Merck, 70~230 mesh) (l kg), with development using 65% PrOH (one fraction was 18ml). The eluates from fraction 131 to fraction 230 were collected and lyophilized to give a pale yellow powder (5.5g), which was applied to a column of Dowex1X4(C1~) (150ml) and eluted wtih H2O. The eluate was lyophilized to give 4.28g of a colorless amorphous powder of 1. 1: (a) Nature: Basic, water soluble, colorless powder, labile in dil A mixture ofa peptide (1 mg) and 6n HC1 (0.5ml) was heated at 110°C for 20hours in a sealed tube. The hydrolysate, after concentration in vacuo to dryness on a water-bath at 60°C, was adjusted to a solution of 20 nmol/ml by adding a solution of sodium citrate (pH 2.2). The solution of250 //I was analyzed with an amino acid analyzer.
The acid hydrolysate of 1 (165 mg) with 6n HC1 (10ml), after concentration to dryness, was subjected EdmanDegradations (a) Edmandegradation was carried out as usual, (b) Proline specific endopeptidase reaction: A solution ofproline endopeptidase (58 u/vial, Seikagaku Kogyo Co., Ltd.) in 0.05 m phosphate buffer (10/zl, pH 7.0) was added to a solution of PA48009 (500/xg) in dioxane (12.5^1) and 0.1 m phosphate buffer (50/4 pH 7.0). After the air of the reaction mixture was displaced by nitrogen gas, the mixture was incubated at 37°C for 5 days. The objective was isolated from the reaction mixture, after concentration to dryness, by HPLC(column: Nucleosil-5-C18 (4.6 i.d. x 150mm); mobile phase: 0.1% TFA->40%CH3CN-0.1% TFA, flow rate: l.O m/minute; detection: 220 nm (UV); Rt: 24minutes). The purified material was subjected to automatic Edman degradation. The result is shown on Fig. 2(b) .
